Agents for the Prevention and Treatment of HIV and Other Viral Infections

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention introduces an agent, containing at least one peptide or its variants, aimed at preventing and/or treating HIV and other viral infections. The agent is notable because the peptide is also known for its suitability in preventing Alzheimer's disease-related fibril formation.

Use CasesContent extracted from patent full text and abstract with AI.

• Prevention of HIV infection in at-risk populations
• Therapeutic treatment for individuals already infected with HIV
• Prevention or treatment of other viral infections beyond HIV
• Potential use in preventing peptide aggregation linked to Alzheimer's disease

BenefitsContent extracted from patent full text and abstract with AI.

• Dual action: can address both viral infections (like HIV) and prevent peptide fibril aggregation associated with Alzheimer's disease
• Potential for broad-spectrum viral prevention or therapy
• Peptide-based approach may offer improved safety and specificity compared to traditional therapies
• May fill unmet needs in prevention for people at high risk of both viral infections and neurodegenerative diseases

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The invention relates to an agent for the prevention and/or therapy of HIV and other viral infections. The agent contains at least one peptide with an amino acid sequence that is suitable for the prevention of fibrils associated with Alzheimer's dementia and/or homologues, fragments and parts thereof, for the treatment and/or prevention of HIV and/or other viral infections.